Risk-Adapted Chemotherapy of Germ Cell Tumors with Carboplatin, Etoposide and Bleomycin for Low-Risk and Cisplatin, Etoposide and Ifosfamide for High-Risk Patients

Publisher： Karger

E-ISSN： 1423-0232|59|2|110-117

ISSN： 0030-2414

Source： Oncology, Vol.59, Iss.2, 2000-08, pp. : 110-117

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

One Cycle of Bleomycin, Etoposide and Cisplatin plus Two Cycles of Etopeside and Cisplatin Chemotherapy in Selected Patients with Low-Volume Stage II Nonseminomatous Germ Cell Tumor of the Testis

By  

Urologia Internationalis, Vol. 75, Iss. 4, 2005-12 ,pp. : 304-308

Karger

Access to resources Recommend Favorite

ICE (Ifosfamide, Carboplatin, Etoposide) Chemotherapy and Systemic Hyperthermia

By  

Oncology Research and Treatment, Vol. 21, Iss. 2, 1998-06 ,pp. : 10-11

Karger

Access to resources Recommend Favorite

Efficacy of Consolidation High-Dose Chemotherapy with Ifosfamide, Carboplatin and Etoposide (HD-ICE) Followed by Autologous Peripheral Blood Stem Cell Rescue in Chemosensitive Patients with Metastatic Soft Tissue Sarcomas

By  

Oncology, Vol. 71, Iss. 1-2, 2007-04 ,pp. : 32-39

Karger

Access to resources Recommend Favorite

Patterns of Relapse after Chemotherapy in Patients with High-Risk Non-Seminomatous Germ Cell Tumor

By  

Oncology, Vol. 78, Iss. 1, 2010-03 ,pp. : 47-53

Karger

Access to resources Recommend Favorite

Risk-Adapted Chemotherapy in the Adjuvant Setting of Breast Cancer

By  

Oncology Research and Treatment, Vol. 23, Iss. 3, 2000-07 ,pp. : 200-201

Karger

Access to resources Recommend Favorite